Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark D Huffman

Showing results (291-300 of 326) with videos related to

Pageof 33
Sort By:
Global Heart|May 14, 2016
The Heart of 25 by 25: Achieving the Goal of Reducing Global and Regional Premature Deaths From Cardiovascular Diseases and Stroke: A Modeling Study From the American Heart Association and World Heart FederationRalph L Sacco, Gregory A Roth, K Srinath Reddy, et al.
Nutrients|January 8, 2023
Sodium Content and Labelling of Packaged Foods and Beverages in Nigeria: A Cross-Sectional StudyAdedayo E Ojo, Alexandra Jones, Clementina Ebere Okoro, et al.
Journal of the American College of Cardiology|December 3, 2025
Aspirin Prophylaxis for Preeclampsia Prevention in Nigeria: An Explanatory Sequential Mixed Methods StudyZainab Mahmoud, Laura Crook, Chibundo Onyia, et al.
JAMA Network Open|September 6, 2022
Characteristics and Patterns of Retention in Hypertension Care in Primary Care Settings From the Hypertension Treatment in Nigeria ProgramJiancheng Ye, Ikechukwu A Orji, Abigail S Baldridge, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|January 20, 2023
Fixed-dose combination therapy-based protocol compared with free pill combination protocol: Results of a cluster randomized trialOlutobi A Sanuade, Boni M Ale, Abigail S Baldridge, et al.
Plos One|January 13, 2023
Stakeholder perspectives on Nigeria's national sodium reduction program: Lessons for implementation and scale-upOlutobi A Sanuade, Vanessa Alfa, Xuejun Yin, et al.
American Heart Journal|September 18, 2022
Efficacy and safety of a quadruple ultra-low-dose treatment for hypertension (QUARTET USA): Rationale and design for a randomized controlled trialAbigail S Baldridge, Mark D Huffman, Danielle Lazar, et al.
Lancet (London, England)|September 1, 2021
Fixed-dose combination therapies with and without aspirin for primary prevention of cardiovascular disease: an individual participant data meta-analysisPhilip Joseph, Gholamreza Roshandel, Peggy Gao, et al.
Implementation Science : IS|November 27, 2025
Implementation outcomes from the Hypertension Treatment in Nigeria program: results from a type 2 hybrid interrupted time series trialJiancheng Ye, Lisa R Hirschhorn, Abigail S Baldridge, et al.
Journal of Hypertension|January 16, 2022
Characteristics, treatment, and control of hypertension in public primary healthcare centers in Nigeria: baseline results from the Hypertension Treatment in Nigeria ProgramDike B Ojji, Abigail S Baldridge, Ikechukwu A Orji, et al.
Pageof 33

Showing results (291-300 of 326) with videos related to

Sort By:
Pageof 33
Global Heart|May 14, 2016
The Heart of 25 by 25: Achieving the Goal of Reducing Global and Regional Premature Deaths From Cardiovascular Diseases and Stroke: A Modeling Study From the American Heart Association and World Heart FederationRalph L Sacco, Gregory A Roth, K Srinath Reddy, et al.
Nutrients|January 8, 2023
Sodium Content and Labelling of Packaged Foods and Beverages in Nigeria: A Cross-Sectional StudyAdedayo E Ojo, Alexandra Jones, Clementina Ebere Okoro, et al.
Journal of the American College of Cardiology|December 3, 2025
Aspirin Prophylaxis for Preeclampsia Prevention in Nigeria: An Explanatory Sequential Mixed Methods StudyZainab Mahmoud, Laura Crook, Chibundo Onyia, et al.
JAMA Network Open|September 6, 2022
Characteristics and Patterns of Retention in Hypertension Care in Primary Care Settings From the Hypertension Treatment in Nigeria ProgramJiancheng Ye, Ikechukwu A Orji, Abigail S Baldridge, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|January 20, 2023
Fixed-dose combination therapy-based protocol compared with free pill combination protocol: Results of a cluster randomized trialOlutobi A Sanuade, Boni M Ale, Abigail S Baldridge, et al.
Plos One|January 13, 2023
Stakeholder perspectives on Nigeria's national sodium reduction program: Lessons for implementation and scale-upOlutobi A Sanuade, Vanessa Alfa, Xuejun Yin, et al.
American Heart Journal|September 18, 2022
Efficacy and safety of a quadruple ultra-low-dose treatment for hypertension (QUARTET USA): Rationale and design for a randomized controlled trialAbigail S Baldridge, Mark D Huffman, Danielle Lazar, et al.
Lancet (London, England)|September 1, 2021
Fixed-dose combination therapies with and without aspirin for primary prevention of cardiovascular disease: an individual participant data meta-analysisPhilip Joseph, Gholamreza Roshandel, Peggy Gao, et al.
Implementation Science : IS|November 27, 2025
Implementation outcomes from the Hypertension Treatment in Nigeria program: results from a type 2 hybrid interrupted time series trialJiancheng Ye, Lisa R Hirschhorn, Abigail S Baldridge, et al.
Journal of Hypertension|January 16, 2022
Characteristics, treatment, and control of hypertension in public primary healthcare centers in Nigeria: baseline results from the Hypertension Treatment in Nigeria ProgramDike B Ojji, Abigail S Baldridge, Ikechukwu A Orji, et al.
Pageof 33